193 related articles for article (PubMed ID: 21823062)
1. Cardiovascular events in thyroid disease: a population based, prospective study.
Schultz M; Kistorp C; Raymond I; Dimsits J; Tuxen C; Hildebrandt P; Faber J
Horm Metab Res; 2011 Aug; 43(9):653-9. PubMed ID: 21823062
[TBL] [Abstract][Full Text] [Related]
2. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
[TBL] [Abstract][Full Text] [Related]
4. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM
Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079
[TBL] [Abstract][Full Text] [Related]
5. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[TBL] [Abstract][Full Text] [Related]
6. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.
Selmer C; Olesen JB; Hansen ML; von Kappelgaard LM; Madsen JC; Hansen PR; Pedersen OD; Faber J; Torp-Pedersen C; Gislason GH
J Clin Endocrinol Metab; 2014 Jul; 99(7):2372-82. PubMed ID: 24654753
[TBL] [Abstract][Full Text] [Related]
7. Association between serum free thyroxine concentration and atrial fibrillation.
Gammage MD; Parle JV; Holder RL; Roberts LM; Hobbs FD; Wilson S; Sheppard MC; Franklyn JA
Arch Intern Med; 2007 May; 167(9):928-34. PubMed ID: 17502534
[TBL] [Abstract][Full Text] [Related]
8. Subclinical thyroid dysfunction and blood pressure: a community-based study.
Walsh JP; Bremner AP; Bulsara MK; O'Leary P; Leedman PJ; Feddema P; Michelangeli V
Clin Endocrinol (Oxf); 2006 Oct; 65(4):486-91. PubMed ID: 16984241
[TBL] [Abstract][Full Text] [Related]
9. Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.
Westerink J; van der Graaf Y; Faber DR; Spiering W; Visseren FL;
Eur J Prev Cardiol; 2012 Aug; 19(4):864-73. PubMed ID: 21724680
[TBL] [Abstract][Full Text] [Related]
10. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
12. Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism.
Das G; Ojewuyi TA; Baglioni P; Geen J; Premawardhana LD; Okosieme OE
Clin Endocrinol (Oxf); 2012 Jul; 77(1):146-51. PubMed ID: 22283624
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function and cholesterol level: paradoxical findings in large groups of population with high cholesterol food intake.
Langer P; Kocan A; Tajtakova M; Petrik J; Koska J; Hucková M; Hanzen E; Ksinantova L; Radikova Z; Imrich R; Trnovec T; Blazicek P; Sebokova E; Klimes I
Endocr Regul; 2003 Sep; 37(3):175-80. PubMed ID: 14986723
[TBL] [Abstract][Full Text] [Related]
14. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years.
Kvetny J; Heldgaard PE; Bladbjerg EM; Gram J
Clin Endocrinol (Oxf); 2004 Aug; 61(2):232-8. PubMed ID: 15272919
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular morbidity and mortality in thyroid dysfunction.
Dörr M; Völzke H
Minerva Endocrinol; 2005 Dec; 30(4):199-216. PubMed ID: 16319809
[TBL] [Abstract][Full Text] [Related]
16. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study.
Heeringa J; Hoogendoorn EH; van der Deure WM; Hofman A; Peeters RP; Hop WC; den Heijer M; Visser TJ; Witteman JC
Arch Intern Med; 2008 Nov; 168(20):2219-24. PubMed ID: 19001198
[TBL] [Abstract][Full Text] [Related]
17. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular consequences of thyroid diseases, their prevalence and treatment, particularly in cases with subclinical hyper- and hypothyroidism].
Molnár I
Orv Hetil; 2005 Oct; 146(40):2067-72. PubMed ID: 16259335
[TBL] [Abstract][Full Text] [Related]
19. Thyroid status, cardiovascular risk, and mortality in older adults.
Cappola AR; Fried LP; Arnold AM; Danese MD; Kuller LH; Burke GL; Tracy RP; Ladenson PW
JAMA; 2006 Mar; 295(9):1033-41. PubMed ID: 16507804
[TBL] [Abstract][Full Text] [Related]
20. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators.
Krahn AD; Klein GJ; Kerr CR; Boone J; Sheldon R; Green M; Talajic M; Wang X; Connolly S
Arch Intern Med; 1996 Oct; 156(19):2221-4. PubMed ID: 8885821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
